Stay updated with breaking news from Vivos Method. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vivos Therapeutics (NASDAQ:VVOS) CEO Kirk Huntsman joined Steve Darling from Proactive to share news the company has announced it has acquired certain U.S....
Vivos Therapeutics has expanded its portfolio with the addition of lower-cost products for treating conditions associated with OSA.
LITTLETON, Colo., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company...
The U.S. Food and Drug Administration gave 510(k) clearance to Vivos Therapeutics' daytime-nighttime obstructive sleep apnea device.
Call Scheduled for Tuesday, December 20, 2022 at 5:00 pm ET...